Table 1 Participant characteristics in model 1
From: Integrated extracellular microRNA profiling for ovarian cancer screening
Characteristics | Total (N = 3187) | Discovery set (N = 1539) | Validation set (N = 1648) | |||||
---|---|---|---|---|---|---|---|---|
N | N | Mean | SD | N | Mean | SD | p | |
Ovarian carcinoma | 333 | 160 | 160 | |||||
Age, years | 56.8 | 11.5 | 57.1 | 11.6 | 0.97a | |||
Histopathological subtypes | 0.29b | |||||||
Serous | 182 | 90 | 92 | |||||
Clear cell | 64 | 37 | 27 | |||||
Endometrioid | 43 | 17 | 26 | |||||
Mucinous | 14 | 6 | 8 | |||||
Other epithelial carcinoma | 17 | 10 | 7 | |||||
Non-epithelial carcinoma | 13 | 13 | ||||||
Stage | 0.97b | |||||||
I | 82 | 39 | 43 | |||||
II | 33 | 15 | 18 | |||||
III–IV | 218 | 106 | 112 | |||||
Borderline ovarian tumor | 66 | 66 | ||||||
Benign ovarian tumor | 29 | 29 | ||||||
Non-cancer cohort | 2759 | 1379 | 1380 | |||||
Institute A | 209 | 100 | 109 | |||||
Institute B | 1581 | 792 | 789 | |||||
Institute C | 969 | 487 | 482 |